SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study

References

• Dejaco C, Alunno A, Bijlsma JW, Boonen A, Combe B, Finckh A, Machado PM, Padjen I, Sivera F, Stamm TA, et al. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Ann Rheum Dis. 2020:1–9.
   Google Scholar
• Antony A, Connelly K, De Silva T, Eades L, Tillett W, Ayoub S, Morand E. Perspectives of patients with rheumatic diseases in the early phase of COVID-19. Arthritis Care Res (Hoboken). 2020;72(9):1189–95. doi:10.1002/acr.24347.
   PubMed Web of Science ®Google Scholar
• Romao VC, Cordeiro I, Macieira C, Oliveira-Ramos F, Romeu JC, Rosa CM, Saavedra MJ, Saraiva F, Vieira-Sousa E, Fonseca JE, et al. Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view. RMD Open. 2020;6(2):e001314. doi:10.1136/rmdopen-2020-001314.
   PubMed Web of Science ®Google Scholar
• Benucci M, Damiani A, Giannasi G, Li Gobbi F, Quartuccio L, Grossi V, Infantino M, Manfredi M. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020. doi:10.1136/annrheumdis-2020-218214.
   Google Scholar
• Francesconi P, Cantini F, Profili F, Mannoni A, Bellini B, Benucci M. COVID-19 epidemiology in rheumatic diseases in Tuscany: a case-control study. Joint Bone Spine. 2021;88(3):105131. doi:10.1016/j.jbspin.2021.105131.
   PubMed Web of Science ®Google Scholar
• Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157–76, ix–x. doi:10.1016/j.rdc.2015.08.004.
   PubMed Web of Science ®Google Scholar
• Arnold J, Winthrop K, Emery P. COVID-19 vaccination and antirheumatic therapy. Rheumatology (Oxford). 2021. doi:10.1093/rheumatology/keab223.
   Google Scholar
• Force, A.C.-V.C.G.T. COVID-19 vaccine clinical guidance summary for patients with rheumatic and musculoskeletal diseases. A.C.o. Rheumatology, Editor; 2021.
   Google Scholar
• Landewe RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, Combe B, Galli M, Gossec L, Iagnocco A, et al. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020;79(7):851–58. doi:10.1136/annrheumdis-2020-217877.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020;27:225–228.
   Web of Science ®Google Scholar
• Dodd RH, Pickles K, Nickel B, Cvejic E, Ayre J, Batcup C, Bonner C, Copp T, Cornell S, Dakin T, et al. Concerns and motivations about COVID-19 vaccination. Lancet Infect Dis. 2021;21(2):161–63. doi:10.1016/S1473-3099(20)30926-9.
   PubMed Web of Science ®Google Scholar
• Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ, Ayre J, Batcup C, Copp T, Cornell S, Dakin T, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(3):318–19. doi:10.1016/S1473-3099(20)30559-4.
   PubMed Web of Science ®Google Scholar
• Felten R, Dubois M, Ugarte-Gil MF, Chaudier A, Kawka L, Bergier H, Costecalde C, Pijnenburg L, Fort J, Chatelus E, et al. Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases. Lancet Rheumatol. 2021;3(4):e243–e245. doi:10.1016/S2665-9913(21)00039-4.
   PubMedGoogle Scholar
• Campochiaro C, Trignani G, Tomelleri A, Cascinu S, Dagna L. Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey. Ann Rheum Dis. 2021;80(6):816–17. doi:10.1136/annrheumdis-2020-219811.
   PubMed Web of Science ®Google Scholar
• Michel M, Vincent FB, Rio S, Leon N, Marcelli C. Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs. Joint Bone Spine. 2016;83(2):237–38. doi:10.1016/j.jbspin.2015.02.016.
   PubMed Web of Science ®Google Scholar
• Al Nokhatha S, MacEoin N, Conway R. Correspondence on ‘Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.’ Ann Rheum Dis. 2021. doi:10.1136/annrheumdis-2021-219847.
   PubMedGoogle Scholar
• Byravan S, Fardanesh A, Tahir H, Moorthy A. Emerging COVID-19 vaccines: a rheumatology perspective. Int J Rheum Dis. 2021;24(2):144–46. doi:10.1111/1756-185X.14048.
   PubMed Web of Science ®Google Scholar
• Loubet P, Kernéis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine. 2015;33(31):3703–08. doi:10.1016/j.vaccine.2015.06.012.
   PubMed Web of Science ®Google Scholar
• Hmamouchi I, Winthrop K, Launay O, Dougados M. Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. Vaccine. 2015;33(12):1446–52. doi:10.1016/j.vaccine.2015.01.065.
   PubMed Web of Science ®Google Scholar
• Figueroa-Parra G, Esquivel-Valerio JA, Santoyo-Fexas L, Moreno-Salinas A, Gamboa-Alonso CM, De Leon-Ibarra AL, Galarza-Delgado DA. Knowledge and attitudes about influenza vaccination in rheumatic diseases patients. Hum Vaccines Immunother. 2020;17:1–6.
   PubMedGoogle Scholar
• Organization, W.H. COVID-19 weekly epidemiological update. 2021 [accessed 2021 Mar 03]. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—23-march-2021 .
   Google Scholar
• Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382(21):1969–73. doi:10.1056/NEJMp2005630.
   PubMed Web of Science ®Google Scholar
• Borriello A, Master D, Pellegrini A, Rose JM. Preferences for a COVID-19 vaccine in Australia. Vaccine. 2021;39(3):473–79. doi:10.1016/j.vaccine.2020.12.032.
   PubMed Web of Science ®Google Scholar
• Park JK, Lee YJ, Shin K, Ha YJ, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis. 2018;77(6):898–904.
   PubMed Web of Science ®Google Scholar
• Association, A.R. COVID-19 vaccination for rheumatology patients. A.R. Association, Editor; 2021.
   Google Scholar
• Connolly CM, Ruddy JA, Boyarsky BJ, Avery RK, Werbel WA, Segev DL, Garonzik-Wang J, Paik JJ. Safety ofthefirstdose ofmRNA SARS-CoV-2vaccines inpatients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021;80:1100–01. doi:10.1136/annrheumdis-2021-220231.
   PubMedGoogle Scholar
• Geisen UM, Berner DK, Tran F, Sümbül M, Vullriede L, Ciripoi M, Reid HM, Schaffarzyk A, Longardt AC, Franzenburg J, et al. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann Rheum Dis. 2021. doi:10.1136/annrheumdis-2021-220272.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Wyka K, Rauh L, Rabin K, Ratzan S, Gostin LO, Larson HJ, El-Mohandes A. Hesitant or Not? The association of age, gender, and education with potential acceptance of a COVID-19 vaccine: a country-level analysis. J Health Commun. 2020;25(10):799–807. doi:10.1080/10810730.2020.1868630.
   PubMed Web of Science ®Google Scholar
• Jain J, Saurabh S, Kumar P, Verma MK, Goel AD, Gupta MK, Bhardwaj P, Raghav PR. COVID-19 vaccine hesitancy among medical students in India. Epidemiol Infect. 2021;149:e132. doi:10.1017/S0950268821001205.
   PubMed Web of Science ®Google Scholar
• Praveen SV, Ittamalla R, Deepak G. Analyzing the attitude of Indian citizens towards COVID-19 vaccine - A text analytics study. Diabetes Metab Syndr. 2021;15(2):595–99. doi:10.1016/j.dsx.2021.02.031.
   PubMed Web of Science ®Google Scholar
• Tsai FJ, Yang H-W, Lin C-P, Liu JZ. Acceptability of COVID-19 vaccines and protective behavior among adults in Taiwan: associations between risk perception and willingness to vaccinate against COVID-19. Int J Environ Res Public Health. 2021;18(11):5579. doi:10.3390/ijerph18115579.
   PubMed Web of Science ®Google Scholar